Lazard Asset Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18.1M | Sell |
251,938
-16,841
| -6% | -$1.3M | 0.03% | 344 |
|
|
2025
Q4 | $21.3M | Sell |
268,779
-80,582
| -23% | -$6.35M | 0.04% | 309 |
|
|
2025
Q3 | $26.3M | Buy |
349,361
+9,722
| +3% | +$666K | 0.04% | 269 |
|
|
2025
Q2 | $23.4M | Buy |
339,639
+22,639
| +7% | +$1.48M | 0.03% | 362 |
|
|
2025
Q1 | $21.5M | Sell |
317,000
-3,973,953
| -93% | -$238M | 0.03% | 332 |
|
|
2024
Q4 | $193M | Buy |
4,290,953
+293,406
| +7% | +$16.5M | 0.28% | 83 |
|
|
2024
Q3 | $251M | Buy |
3,997,547
+267,412
| +7% | +$15.6M | 0.34% | 69 |
|
|
2024
Q2 | $220M | Sell |
3,730,135
-2,968,444
| -44% | -$186M | 0.28% | 73 |
|
|
2024
Q1 | $534M | Buy |
6,698,579
+124,237
| +2% | +$9.49M | 0.65% | 40 |
|
|
2023
Q4 | $519M | Buy |
6,574,342
+2,244,994
| +52% | +$160M | 0.66% | 40 |
|
|
2023
Q3 | $302M | Buy |
4,329,348
+336,646
| +8% | +$23.9M | 0.41% | 56 |
|
|
2023
Q2 | $276M | Buy |
3,992,702
+764,453
| +24% | +$54.4M | 0.34% | 68 |
|
|
2023
Q1 | $240M | Buy |
3,228,249
+607,696
| +23% | +$51M | 0.31% | 79 |
|
|
2022
Q4 | $244M | Sell |
2,620,553
-166,028
| -6% | -$16M | 0.34% | 73 |
|
|
2022
Q3 | $266M | Buy |
2,786,581
+101,878
| +4% | +$10.1M | 0.39% | 61 |
|
|
2022
Q2 | $249M | Buy |
2,684,703
+316,404
| +13% | +$30.9M | 0.34% | 66 |
|
|
2022
Q1 | $240M | Sell |
2,368,299
-245,646
| -9% | -$25.8M | 0.28% | 76 |
|
|
2021
Q4 | $270M | Sell |
2,613,945
-256,907
| -9% | -$23.7M | 0.29% | 76 |
|
|
2021
Q3 | $244M | Sell |
2,870,852
-234,625
| -8% | -$19.7M | 0.27% | 79 |
|
|
2021
Q2 | $259M | Sell |
3,105,477
-44,594
| -1% | -$3.65M | 0.29% | 80 |
|
|
2021
Q1 | $237M | Sell |
3,150,071
-96,466
| -3% | -$7.03M | 0.29% | 83 |
|
|
2020
Q4 | $222M | Buy |
3,246,537
+1,090,493
| +51% | +$70.9M | 0.28% | 88 |
|
|
2020
Q3 | $126M | Buy |
2,156,044
+428,888
| +25% | +$26.7M | 0.18% | 110 |
|
|
2020
Q2 | $112M | Buy |
1,727,156
+479,480
| +38% | +$30.2M | 0.17% | 114 |
|
|
2020
Q1 | $74M | Sell |
1,247,676
-3,377,654
| -73% | -$225M | 0.14% | 125 |
|
|
2019
Q4 | $344M | Buy |
4,625,330
+574,325
| +14% | +$40.3M | 0.49% | 51 |
|
|
2019
Q3 | $255M | Buy |
4,051,005
+372,902
| +10% | +$22.1M | 0.42% | 62 |
|
|
2019
Q2 | $200M | Buy |
3,678,103
+183,585
| +5% | +$9.89M | 0.33% | 78 |
|
|
2019
Q1 | $188M | Buy |
3,494,518
+730,974
| +26% | +$45.1M | 0.31% | 78 |
|
|
2018
Q4 | $181M | Sell |
2,763,544
-10,180
| -0.4% | -$760K | 0.33% | 72 |
|
|
2018
Q3 | $218M | Buy |
2,773,724
+2,238,815
| +419% | +$160M | 0.35% | 73 |
|
|
2018
Q2 | $34.4M | Buy |
534,909
+329,050
| +160% | +$21.7M | 0.06% | 213 |
|
|
2018
Q1 | $16.5M | Sell |
205,859
-139,971
| -40% | -$10M | 0.03% | 334 |
|
|
2017
Q4 | $25.1M | Buy |
345,830
+9,385
| +3% | +$682K | 0.04% | 266 |
|
|
2017
Q3 | $27.4M | Buy |
336,445
+105,543
| +46% | +$8.35M | 0.05% | 246 |
|
|
2017
Q2 | $18.6M | Sell |
230,902
-3,595
| -2% | -$284K | 0.03% | 311 |
|
|
2017
Q1 | $18.4M | Sell |
234,497
-494,521
| -68% | -$39.5M | 0.03% | 316 |
|
|
2016
Q4 | $57.5M | Sell |
729,018
-2,514,600
| -78% | -$203M | 0.12% | 132 |
|
|
2016
Q3 | $289M | Sell |
3,243,618
-112,719
| -3% | -$10.6M | 0.57% | 52 |
|
|
2016
Q2 | $321M | Sell |
3,356,337
-437,724
| -12% | -$43.6M | 0.68% | 40 |
|
|
2016
Q1 | $394M | Sell |
3,794,061
-50,205
| -1% | -$4.88M | 0.86% | 30 |
|
|
2015
Q4 | $376M | Buy |
3,844,266
+369,733
| +11% | +$36.2M | 0.86% | 29 |
|
|
2015
Q3 | $335M | Buy |
3,474,533
+1,262,620
| +57% | +$133M | 0.8% | 32 |
|
|
2015
Q2 | $232M | Sell |
2,211,913
-54,229
| -2% | -$5.54M | 0.49% | 59 |
|
|
2015
Q1 | $234M | Sell |
2,266,142
-314,256
| -12% | -$31.8M | 0.5% | 57 |
|
|
2014
Q4 | $249M | Sell |
2,580,398
-897,066
| -26% | -$79M | 0.53% | 55 |
|
|
2014
Q3 | $277M | Sell |
3,477,464
-482,759
| -12% | -$38.1M | 0.59% | 45 |
|
|
2014
Q2 | $298M | Sell |
3,960,223
-3,171,687
| -44% | -$240M | 0.62% | 45 |
|
|
2014
Q1 | $534M | Sell |
7,131,910
-1,423,119
| -17% | -$101M | 1.19% | 18 |
|
|
2013
Q4 | $612M | Sell |
8,555,029
-622,417
| -7% | -$40M | 1.36% | 11 |
|
|
2013
Q3 | $521M | Sell |
9,177,446
-1,171,893
| -11% | -$69.8M | 1.24% | 17 |
|
|
2013
Q2 | $592M | Buy |
+10,349,339
| New | +$600M | 1.4% | 15 |
|
Other funds holding CVS
VCM
VPM
Lazard Asset Management's CVS Position: Q1 2026 in Review
Lazard Asset Management reduced its CVS Health (CVS) stake by 6.3% in Q1 2026, selling an estimated $1.3M and leaving 251,938 shares worth $18.1M. The position accounts for 0.03% of the portfolio, ranked #344.
Lazard Asset Management first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $612M in Q4 2013. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Lazard Asset Management held 251,938 shares of CVS Health worth $18.1M as of Q1 2026.
- Lazard Asset Management sold 16,841 CVS Health shares in Q1 2026, an estimated $1.3M.
- CVS Health made up 0.03% of Lazard Asset Management's portfolio in Q1 2026, its #344 holding.
- Lazard Asset Management first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
- Lazard Asset Management's CVS Health position peaked at $612M in Q4 2013.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.